COMMUNIQUÉS West-GlobeNewswire

Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d'administration lors de l'Assemblée générale
02/03/2018
Les actionnaires approuvent la 21 e hausse consécutive du dividende, à CHF 2,80 (+2 %) par action au titre de l'exercice 2017, soit un rendement de 3,6 % et une distribution du free cash-flow d'environ 67 %. Le Dr Joerg [...]
ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018
02/03/2018
Geneva, Switzerland and Boston, MA - March 2, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Calithera Biosciences to Report Fourth Quarter 2017 Financial Results on Thursday, March 8, 2018
02/03/2018
SOUTH SAN FRANCISCO, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs [...]
TearLab Corporation Reports Fourth Quarter and Full Year 2017 Financial Results
02/03/2018
SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended [...]
Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference
02/03/2018
NEW HAVEN, Conn., March 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage pharmaceutical company developing and commercializing novel antibiotics to treat serious bacterial [...]
Cannabis Wheaton Income Corp. Announces Filing of Amended and Restated Final Base Shelf Prospectus
02/03/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis [...]
BIONOVELUS C.I.O.DEPARTURE
02/03/2018
FOR IMMEDIATE RELEASE / Phoenix, March 02, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (ONOV), whose CR-10® Biofungicide is a non-toxic solution for safe and effective pre- and post-harvest applications, is announcing [...]
Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies
02/03/2018
BERKELEY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (“Dynavax”) (NASDAQ: DVAX ) announced today that Stanley A. Plotkin, M.D. has indicated his intention to step down from the Board of [...]
ChromaDex Sets Fourth Quarter and Full Year 2017 Conference Call for Thursday, March 8, 2018 at 4:30 p.m. ET
02/03/2018
IRVINE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, will hold a [...]
Orion Corporation: Managers' transactions - Olli Huotari
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Timo Lappalainen
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation [...]
Orion Corporation: Managers' transactions - Virve Laitinen
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]
Orion Corporation: Managers' transactions - Satu Ahomäki
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Markku Huhta-Koivisto
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Jari Karlson
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Christer Nordstedt
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Liisa Hurme
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
Oasmia Pharmaceutical AB (publ)
02/03/2018
Interim report for the period May 2017 – January 2018 Commercial focus and lower cost base THIRD QUARTER November 1, 2017 – January 31, 2018 Consolidated net sales amounted to TSEK 656 compared to TSEK 36 in the third [...]
Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2017
02/03/2018
Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2017 Clinical development progressed as planned Highlights in January-December 2017: Phase 1 clinical study of Herantis Pharma ("Herantis") [...]

Pages